Skip to main content

PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population

Abstract

Cytidine deaminase (CDA) is a pyrimidine salvage pathway enzyme that catalyzes the hydrolytic deamination of cytidine and deoxycytidine to their corresponding uracil nucleosides. CDA also catalyzes the inactivation of some chemotherapeutic nucleoside analogues such as cytosine arabinoside and gemcitabine. CDA 79A > C (K27Q, rs2072671) and 208G > A (A70T, rs60369023) were found to be associated either with clinical outcomes as well as with pharmacokinetics and toxicity of drugs administered to different subsets of patients. In this paper we reported two PCR-based methods for CDA 79A > C (K27Q) and 208G > A (A70T) genotyping and tested their feasibility using DNA extracted from whole blood as well as from buccal swabs. The aim of this study was also to assess the distribution of genotypic variants in a central Italy population. The allele frequencies were 56.3% (K*) and 43.7% (Q*) for K27Q and 100% (A*) and 0% (T*) for A70T. The genotype frequencies were 32.8% (K*/K*), 46.9% (K*/Q*) and 20.3% (Q*/Q*) for K27Q. The genotype frequencies did not deviate from Hardy–Weinberg equilibrium. The results were compared with those of other reported populations. They showed marked ethnic group differences.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Vincenzetti S, Cambi A, Neuhard J, Garattini E, Vita A (1996) Recombinant human cytidine deaminase: expression, purification, and characterization. Protein Expr Purif 8:247–253

    Article  CAS  PubMed  Google Scholar 

  2. Watanabe S, Uchida T (1996) Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha, 25-dihydroxyvitamin D3. Biochim Biophys Acta 1312:99–104

    Article  PubMed  Google Scholar 

  3. Ho DH, Frei E (1971) Clinical pharmacology of 1-beta-darabinofuranosyl cytosine. Clin Pharmacol Ther 12:944–954

    CAS  PubMed  Google Scholar 

  4. Cacciamani T, Vita A, Cristalli G et al (1991) Purification of human cytidine deaminase: molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs. Arch Biochem Biophys 290:285–292

    Article  CAS  PubMed  Google Scholar 

  5. Chabner B (1990) Cytidine analogs. In: Chabner BA, Collins JM (eds) Cancer chemotherapy: principals and practice. JB Lippincott, New York, pp 152–179

    Google Scholar 

  6. Betts L, Xiang S, Short SA, Wolfenden R, Carter CW Jr (1994) Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J Mol Biol 235:635–656

    Article  CAS  PubMed  Google Scholar 

  7. Schroder JK, Kirch C, Seeber S, Schutte J (1998) Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia. Br J Haematol 103:1096–1103

    Article  CAS  PubMed  Google Scholar 

  8. Laliberte J, Momparler RL (1994) Human cytidine deaminase: purification of enzyme, cloning, and expression of its complementary DNA. Cancer Res 54:5401–5407

    CAS  PubMed  Google Scholar 

  9. Kirch HC, Schroder J, Hoppe H, Esche H, Seeber S, Schutte J (1998) Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro. Exp Hematol 26:421–425

    CAS  PubMed  Google Scholar 

  10. Kuhn K, Bertling WM, Emmrich F (1993) Cloning of a functional cDNA for human cytidine deaminase (CDD) and its use as a marker of monocyte/macrophage differentiation. Biochem Biophys Res Commun 190:1–7

    Article  CAS  PubMed  Google Scholar 

  11. Fukunaga AK, Marsh S, Murry DJ, Hurley TD, McLeod HL (2004) Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway. Pharmacogenomics J 4:307–314

    Article  CAS  PubMed  Google Scholar 

  12. Yonemori K, Ueno H, Okusaka T et al (2005) Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin. Clin Cancer Res 11:2620–2624

    Article  CAS  PubMed  Google Scholar 

  13. Yue L, Saikawa Y, Ota K, Tanaka M, Uehara T, Maeba H (2003) A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity. Pharmacogenetics 13:29–38

    Article  CAS  PubMed  Google Scholar 

  14. Gilbert JA, Salavaggione OE, Ji Y et al (2006) Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics. Clin Cancer Res 12:1794–1803

    Article  CAS  PubMed  Google Scholar 

  15. Sugiyama E, Kaniwa N, Kim SR et al (2007) Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol 25:32–42

    Article  CAS  PubMed  Google Scholar 

  16. Chew HK, Doroshow JH, Frankel P et al (2009) Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol 27:2163–2169

    Article  CAS  PubMed  Google Scholar 

  17. Bhatla D, Gerbing RB, Alonzo TA et al (2009) Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. Br J Haematol 144:388–394

    Article  CAS  PubMed  Google Scholar 

  18. Giovannetti E, Laan AC, Vasile E et al (2008) Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples. Nucleosides Nucleotides Nucleic Acids 27:720–725

    Article  CAS  PubMed  Google Scholar 

  19. Yue L, Saikawa Y, Ota K, Tanaka M, Nishimura R, Uehara T et al (2003) A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity. Pharmacogenetics 13:29–38

    Article  CAS  PubMed  Google Scholar 

  20. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 11:1215

    Article  Google Scholar 

  21. Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR (1999) Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect 107:517–520

    Article  CAS  PubMed  Google Scholar 

  22. Fitzgerald SM, Goyal RK, Osborne WR, Roy JD, Wilson JW, Ferrell RE (2006) Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter. Hum Genet 119:276–283

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by Department of Morphological Science and Comparative Biochemistry, University of Camerino, Italy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valerio Napolioni.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Carpi, F.M., Vincenzetti, S., Micozzi, D. et al. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population. Mol Biol Rep 37, 3363–3368 (2010). https://doi.org/10.1007/s11033-009-9923-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9923-6

Keywords

  • Cytidine deaminase (CDA)
  • RFLP-PCR
  • Single nucleotide polymorphism
  • Genotyping assay
  • Oncology
  • Gemcitabine
  • Ara-C